- Home
- AUTL vs DRDB Comparison
AUTL vs DRDB Comparison
Compare AUTL & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- DRDB
- Stock Information
- Founded
- AUTL 2014
- DRDB 2024
- Country
- AUTL United Kingdom
- DRDB United States
- Employees
- AUTL N/A
- DRDB N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- DRDB
- Sector
- AUTL Health Care
- DRDB
- Exchange
- AUTL Nasdaq
- DRDB Nasdaq
- Market Cap
- AUTL 359.3M
- DRDB 307.3M
- IPO Year
- AUTL 2018
- DRDB 2024
- Fundamental
- Price
- AUTL $1.27
- DRDB $10.19
- Analyst Decision
- AUTL Strong Buy
- DRDB
- Analyst Count
- AUTL 5
- DRDB 0
- Target Price
- AUTL $9.32
- DRDB N/A
- AVG Volume (30 Days)
- AUTL 2.4M
- DRDB 178.9K
- Earning Date
- AUTL 05-08-2025
- DRDB 01-01-0001
- Dividend Yield
- AUTL N/A
- DRDB N/A
- EPS Growth
- AUTL N/A
- DRDB N/A
- EPS
- AUTL N/A
- DRDB N/A
- Revenue
- AUTL $9,011,000.00
- DRDB N/A
- Revenue This Year
- AUTL $277.74
- DRDB N/A
- Revenue Next Year
- AUTL $221.89
- DRDB N/A
- P/E Ratio
- AUTL N/A
- DRDB $582.11
- Revenue Growth
- AUTL N/A
- DRDB N/A
- 52 Week Low
- AUTL $1.11
- DRDB $9.87
- 52 Week High
- AUTL $5.00
- DRDB $10.19
- Technical
- Relative Strength Index (RSI)
- AUTL 43.50
- DRDB N/A
- Support Level
- AUTL $1.15
- DRDB N/A
- Resistance Level
- AUTL $1.44
- DRDB N/A
- Average True Range (ATR)
- AUTL 0.13
- DRDB 0.00
- MACD
- AUTL 0.01
- DRDB 0.00
- Stochastic Oscillator
- AUTL 29.27
- DRDB 0.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.